Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.87 $1.41 Wednesday, 8th May 2024 ADAP stock ended at $1.14. This is 3.64% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 11.76% from a day low at $1.02 to a day high of $1.14.
90 days $0.87 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Dec 29, 2016 $4.05 $4.18 $4.01 $4.05 117 814
Dec 28, 2016 $4.04 $4.28 $4.00 $4.04 111 153
Dec 27, 2016 $4.16 $4.20 $4.09 $4.16 48 863
Dec 23, 2016 $4.05 $4.09 $3.91 $4.05 75 651
Dec 22, 2016 $3.99 $4.10 $3.95 $3.99 133 878
Dec 21, 2016 $4.00 $4.07 $3.95 $4.00 648 987
Dec 20, 2016 $4.05 $4.06 $3.81 $4.05 192 707
Dec 19, 2016 $3.83 $4.05 $3.81 $3.83 124 998
Dec 16, 2016 $3.95 $3.98 $3.79 $3.95 158 448
Dec 15, 2016 $3.76 $3.97 $3.76 $3.76 99 554
Dec 14, 2016 $3.98 $3.98 $3.85 $3.98 46 637
Dec 13, 2016 $3.98 $4.09 $3.92 $3.98 53 054
Dec 12, 2016 $3.92 $4.37 $3.86 $3.92 160 302
Dec 09, 2016 $4.16 $4.47 $4.05 $4.16 84 090
Dec 08, 2016 $4.20 $4.32 $4.15 $4.20 65 054
Dec 07, 2016 $4.20 $4.45 $4.14 $4.20 78 892
Dec 06, 2016 $4.32 $4.50 $4.08 $4.32 85 577
Dec 05, 2016 $4.21 $4.40 $4.05 $4.21 80 220
Dec 02, 2016 $4.05 $4.32 $4.01 $4.05 109 191
Dec 01, 2016 $4.16 $4.32 $4.10 $4.16 81 076
Nov 30, 2016 $4.17 $4.49 $4.09 $4.17 118 115
Nov 29, 2016 $4.39 $4.86 $4.35 $4.39 228 531
Nov 28, 2016 $4.83 $4.99 $4.75 $4.83 72 444
Nov 25, 2016 $4.98 $5.08 $4.72 $4.98 102 816
Nov 23, 2016 $4.93 $5.07 $4.70 $4.93 50 830
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT